Podcast: No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers





Marc Iskowitz (top), MM&M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin (bottom), VP of virtual engagement at TrialCard.

Click here to download the white paper: "No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers."